Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Accured Expenses: 2019-2024

Historic Change in Accured Expenses for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $16.1 million.

  • Praxis Precision Medicines' Change in Accured Expenses fell 70.84% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 41.79%. This contributed to the annual value of $16.1 million for FY2024, which is 289.60% up from last year.
  • Praxis Precision Medicines' Change in Accured Expenses amounted to $16.1 million in FY2024, which was up 289.60% from -$8.5 million recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' Change in Accured Expenses registered a high of $16.1 million during FY2024, and its lowest value of -$10.5 million during FY2022.
  • In the last 3 years, Praxis Precision Medicines' Change in Accured Expenses had a median value of -$8.5 million in 2023 and averaged -$950,667.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 325.26% in 2020, then crashed by 167.73% in 2022.
  • Yearly analysis of 5 years shows Praxis Precision Medicines' Change in Accured Expenses stood at $7.4 million in 2020, then soared by 108.56% to $15.4 million in 2021, then slumped by 167.73% to -$10.5 million in 2022, then grew by 18.81% to -$8.5 million in 2023, then skyrocketed by 289.60% to $16.1 million in 2024.